The Trump administration is expected to unveil new efforts Monday exploring how one medication may be linked to autism and another one can treat it, according to four people with knowledge of the plans who spoke on the condition of anonymity because the announcement was not yet public.

Dr. Elizabeth Munger discusses research that suggests a possible increased risk linked to the use of Tylenol by pregnant women, highlighted by the Trump admin.

Shares of Tylenol maker Kenvue are dropping in morning trading Monday on a report that the White House is expected to make an announcement Monday linking pregnant women’s use of the painkiller to autism.